{{Rsnum
|rsid=17027130
|Chromosome=2
|position=41046491
|Orientation=plus
|GMAF=0.1331
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 3.1 | 10.8 | 86.2
| HCB | 17.8 | 35.6 | 46.7
| JPT | 25.0 | 45.5 | 29.5
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 17.8 | 35.6 | 46.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=C
  |Pval=3E-6
  |OR=2.87
  |ORtxt=[1.844-4.452]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}